Frozen section for the management of intraoperatively detected palpable tumor lesions during nerve-sparing scheduled radical prostatectomy.

OBJECTIVES The intraoperative finding of palpable tumor lesions has been described as a contraindication for nerve-sparing (NS) radical prostatectomy (RP). However, its evaluation is subjective. Especially in patients with a strong demand to regain postoperative erectile function, a surgeon might be reluctant to sacrifice neurovascular bundles (NVBs) based on this information. We investigated the use of frozen section (FS) analysis to monitor the safety and efficiency of NS during RP in patients with intraoperatively identified subcapsular tumor lesions. METHODS In 83 of 608 patients, who underwent NS-RP, intraoperative FS was performed because of a lesion palpable close to the capsule. A wedge of 4cm in diameter including the lesion was cut off and stained differently for capsule and intraprostatic margin. In case of presence of carcinoma adherent to the capsule, the NVB was resected; otherwise, the NVB remained in situ. RESULTS Patients with palpable tumor lesions had pT3 tumors in 36% and 61% had Gleason 4 pattern, compared to 18% and 42% for the control group. Carcinoma was found in 93% of the FS specimens. In 42% of the FS samples, tumor had contact with the capsule and 14% of secondary resected NVB specimens demonstrated a carcinoma invasion. In 52% NVBs could be preserved despite an ipsilateral nodule without negatively affecting the margin status. However, the false-negative rate of the FSs was 6%. Conversely, FSs set the intraoperative decision to remove the NVB in 42% of FS patients, resulting in an additional 36% of negative margins. CONCLUSIONS In patients with intraoperatively detected tumor lesions during a NS planned RP, FS objectively supports the decision of secondary NVB resection as well as preservation.

[1]  [Do close but negative margins in radical prostatectomy specimens increase the risk of postoperative progression?]. , 1998, Der Urologe. Ausg. A.

[2]  M. Litwin,et al.  Intraoperative frozen section monitoring of nerve sparing radical retropubic prostatectomy. , 1999, The Journal of urology.

[3]  M. Kattan,et al.  Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer. , 2004, The Journal of urology.

[4]  A W Partin,et al.  Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. , 1997, JAMA.

[5]  A. Haese*,et al.  Indication, Technique and Outcome of Retropubic Nerve-Sparing Radical Prostatectomy , 2005 .

[6]  M Bolla,et al.  EAU guidelines on prostate cancer. , 2001, European urology.

[7]  U Pichlmeier,et al.  A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy. , 2001, The Journal of urology.

[8]  P. Validire,et al.  Impact of margin size on the incidence of local residual tumor after laparoscopic radical prostatectomy. , 2004, The Journal of urology.

[9]  M. Soloway,et al.  Prostate specific antigen recurrence rates are low after radical retropubic prostatectomy and positive margins. , 2006, The Journal of urology.

[10]  N. Olson,et al.  Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy. , 1993, The Journal of urology.

[11]  A. Haese*,et al.  Influence of nerve-sparing (NS) procedure during radical prostatectomy (RP) on margin status and biochemical failure. , 2005, European urology.

[12]  A. Haese*,et al.  Patient-reported sexual function after nerve-sparing radical retropubic prostatectomy. , 2002, European urology.

[13]  J. Epstein Evaluation of Radical Prostatectomy Capsular Margins of Resection: The Significance of Margins Designated as Negative, Closely Approaching, and Positive , 1990, American Journal of Surgical Pathology.

[14]  P. Carroll,et al.  Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database. , 2000, The Journal of urology.

[15]  J. Schlesselman,et al.  Risk of positive margins and biochemical recurrence in relation to nerve-sparing radical prostatectomy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  T. Stamey,et al.  Pathological characteristics and prognosis of nonpalpable and palpable prostate cancers with a Hybritech prostate specific antigen of 4 to 10 ng./ml. , 1996, The Journal of urology.

[17]  C. Stocking,et al.  Sex or survival: trade-offs between quality and quantity of life. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  W. Catalona,et al.  Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. , 1999, The Journal of urology.

[19]  Herbert Lepor,et al.  Radical prostatectomy with preservation of sexual function: Anatomical and pathological considerations , 1983, The Prostate.

[20]  C. Abbou,et al.  EAU guidelines on prostate cancer. , 2009, European urology.

[21]  G. Andriole,et al.  Do Margins Matter? The Prognostic Significance of Positive Surgical Margins in Radical Prostatectomy Specimens , 2008 .

[22]  M. Kattan,et al.  Risk factors for urinary incontinence after radical prostatectomy. , 1996, The Journal of urology.

[23]  T. Tsuzuki,et al.  Prediction of extraprostatic extension in the neurovascular bundle based on prostate needle biopsy pathology, serum prostate specific antigen and digital rectal examination. , 2005, Journal of Urology.

[24]  R H Brook,et al.  Quality-of-life outcomes in men treated for localized prostate cancer. , 1995, JAMA.

[25]  W. Catalona,et al.  Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. , 1993, The Journal of urology.

[26]  P. Carroll,et al.  Utility of intraoperative frozen section analysis of surgical margins in region of neurovascular bundles at radical prostatectomy. , 2002, Urology.

[27]  M W Kattan,et al.  Evaluation of a Nomogram used to predict the pathologic stage of clinically localized prostate carcinoma , 1997, Cancer.